Close

Johnson & Johnson (JNJ) Formes Ebola Vaccine Consortium

January 16, 2015 6:45 AM EST Send to a Friend
Johnson & Johnson (NYSE: JNJ) announced the formation of consortia with leading global research institutions and non-government organizations to work ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login